[an error occurred while processing this directive] | ����Ƥ���Բ�ѧ��־ 2007, 33(5) 293-295 DOI: ISSN: 2096-5540 CN: 32-1880/R | ||||||||||||||||||||||||||||||||||||||||||||||||||
����Ŀ¼ | ����Ŀ¼ | ������� | ������ [��ӡ��ҳ] [�ر�] | |||||||||||||||||||||||||||||||||||||||||||||||||||
���� |
| ||||||||||||||||||||||||||||||||||||||||||||||||||
������������ϸ����������ź�ת���ĵ��� | |||||||||||||||||||||||||||||||||||||||||||||||||||
��ʢ��, �ĺ�Ȫ, �Ź�Ӣ | |||||||||||||||||||||||||||||||||||||||||||||||||||
���ϴ�ѧ���Ŷ�ҽԺƤ���� ��ɳ 410011 | |||||||||||||||||||||||||||||||||||||||||||||||||||
ժҪ��
������������ҩ��ֲ��������Ҫҩ����ԵĴ����Ե���֮һ,���п����ߡ����ס���������ҩ�����á�����Ҫ���û����ǻ�����춬ø������˿��ԭ�����ø�ź�ͨ·�����ƺ�����-��B��ʽ�������á��p53ͬʱ����p21�յ����������͵�,�Ӷ��յ�ϸ���������������������ź�ת���ĵ�����ϸ�����ͬ�����ڲ��졣 | |||||||||||||||||||||||||||||||||||||||||||||||||||
�ؼ����� �������� ϸ������ �ź�ת�� | |||||||||||||||||||||||||||||||||||||||||||||||||||
Effects of triptolide on cell apoptosis-related signal transduction | |||||||||||||||||||||||||||||||||||||||||||||||||||
Department of Dermatology, Second Xiangya Hospital, Central South University, Changsha 410011, China | |||||||||||||||||||||||||||||||||||||||||||||||||||
Department of Dermatology, Second Xiangya Hospital, Central South University, Changsha 410011, China | |||||||||||||||||||||||||||||||||||||||||||||||||||
Abstract:
Triptolide, a diterpene triepoxide, is the principal active component of Tripterygium wilfordii Hook. F. abstracts. It has been shown to possess anti-inflammatory, immunosuppressive and anti-neoplastic properties, which are mainly related to the induction of apoptosis via the activation of caspase enzymes, mitogen-activated protein kinase signaling pathway and p53, as well as the inhibition of trans-activation by nuclear factor-��B and growth arrest induced by p21, and so on. The effects of triptolide on the signal transduction vary with the types of cells. | |||||||||||||||||||||||||||||||||||||||||||||||||||
Keywords: Triptolide Apoptosis Signal transduction | |||||||||||||||||||||||||||||||||||||||||||||||||||
�ո����� 2006-12-05 ������ ����淢������ | |||||||||||||||||||||||||||||||||||||||||||||||||||
DOI: | |||||||||||||||||||||||||||||||||||||||||||||||||||
������Ŀ: | |||||||||||||||||||||||||||||||||||||||||||||||||||
ͨѶ����: | |||||||||||||||||||||||||||||||||||||||||||||||||||
�����: | |||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||
�ο����ף� | |||||||||||||||||||||||||||||||||||||||||||||||||||
[1] Liu Q,Chen T,Chen H,et al.Triptolide (PG-490) induces apoptosis of dendritic cells through sequential p38 MAP kinase phosphorylation and caspase 3 activation.Biochem Biophys Res Commun,2004,319 (3):980-986. [2] Choi YJ,Kim TG,Kim YH,et al.Immunosuppressant PG490 (triptolide) induces apoptosis through the activation of caspase-3 and down-regulation of XIAP in U937 cella.Biochem Pharmacol,2003,66 (2):273-280. [3] Yinjun L,Jie J,Yungui W.Triptolide inhibits transcription factor NF-kappaB and induces apoptosis of multiple myeloma cells.Leuk Res,2005,29 (1):99-105. [4] Carter BZ,M ak DH,Schober WD,et al.Triptolide induces caspase-dependent cell death mediated via the mitochondrial pathway in leukemic cells.Blood,2006,108 (2):630637. [5] Kim YH,Lee SH,Lee JY,et al.Triptolide inhibits murine-inducible nitric oxide synthase expression by down-regulating lipopolysaccharide-induced activity of nuclear factor-kappa B and c-Jun NH2-terminal kinase.Eur J Pharmacol,2004,494(1):1-9. [6] Chen P,Li J,Barnes J,et al.Restraint of proinflammatory cytokine biosynthesis by mitogen-activated protein kinase phosphatase-1 in lipopolysaccharide-stimulated macrophages.J Immunol,2002,169 (11):6408-6416. [7] Miyata Y,Sato T,Ito A.Triptolide,a diterpenoid triepoxide,induces antitumor proliferation via activation of c-Jun NH2-terminal kinase 1 by decreasing phosphatidylinositol 3-kinase activity in human tumor cells.Biochem Biophys Res Commun,2005,336(4):1081-1086. [8] Wan CK,Wang C,Cheung HY,et al.Triptolide induces Bcl-2 cleavage and mitochondria dependent apoptosis in p53-deficient HL-60 cells.Cancer Lett,2006,241 (1):31-41. [9] Frese S,Pirnia F,Miescher D,et al.PG490-mediated sensitization of lung cancer cells to APo2L/TRAIL-induced apoptosis requires activation of ERK2.Oncogene,2003,22 (35):5427-5435. [10] Du ZY,Li XY,Li YC,et al.Analysis of triptolide-regulated gene expression in Jurkat cells by complementary DNA microarray.Acta Pharmacol Sin,2003,24 (9):864-872. [11] Wang CY,Cusack JC Jr,Liu R,et al.Control of inducible chemoresistance:enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-kappaB.Nat Med,1999,5(4):412-417. [12] Liu H,Liu ZH,Chen ZH,et al.Triptolide:a potent inhibitor of NF-kappa B in T-lymphocytes.Acta Pharmacol Sin,2000,21(9):782-786. [13] Lee KY,Park JS,Jee YK,et al.Triptolide sensitizes lung cancer cells to TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by inhibition of NF-kappaB activation.Exp Mol Med,2002,34 (6):462-468. [14] Qiu D,Zhao G,Aoki Y,et al.Immunosuppressant PG490 (triptolide) inhibits T-cell interleukin-2 expression at the level of purine-box/nuclear factor of activated T-cells and NF-kappaB transcriptional activation.J Biol Chem,1999,274 (19):13443-13450. [15] Chang WT,Kang JJ,Lee KY,et al.Triptolide and chemotherapy cooperate in tumor cell apoptosis.A role for the p53 pathway.J Biol Chem,2001,276(3):2221-2227. [16] Jiang XH,Wong BC,Lin MC,et al.Functional p53 is required for triptolide-induced apoptosis and AP-1 and nuclear factor-kappaB activation in gastric cancer cells.Oncogene,2001,20(55):8009-8018. [17] Kiviharju TM,Lecane PS,Sellers RG,et al.Antiproliferative and proapoptotic activities of triptolide (PG490),a natural product entering clinical trials,on primary cultures of human prostatic epithelial cells.Clin Cancer Res,2002,8 (8):2666-2674. [18] Yang S,Chen J,Guo Z,et al.Triptolide inhibits the growth and metastasis of solid tumors.Mol Cancer Ther,2003,2 (1):65-72. [19] Fidler JM,Li K,Chung C,et al.PG490-88,a derivative of triptolide,causes tumor regression and sensitizes tumors to chemotherapy.Mol Cancer Ther,2003,2 (9):855-862. |
|||||||||||||||||||||||||||||||||||||||||||||||||||
������������� | |||||||||||||||||||||||||||||||||||||||||||||||||||
�������� (��ע��:��վʵ�������Ը�, �벻Ҫ������ѧ���ص�����!�������ݲ�����վ�۵�.) | |||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright 2008 by ����Ƥ���Բ�ѧ��־ |